Warren H. Schonfeld

839 total citations
21 papers, 662 citations indexed

About

Warren H. Schonfeld is a scholar working on Psychiatry and Mental health, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Warren H. Schonfeld has authored 21 papers receiving a total of 662 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Psychiatry and Mental health, 4 papers in Pulmonary and Respiratory Medicine and 4 papers in Epidemiology. Recurrent topics in Warren H. Schonfeld's work include Health Systems, Economic Evaluations, Quality of Life (3 papers), Prostate Cancer Diagnosis and Treatment (3 papers) and EEG and Brain-Computer Interfaces (3 papers). Warren H. Schonfeld is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (3 papers), Prostate Cancer Diagnosis and Treatment (3 papers) and EEG and Brain-Computer Interfaces (3 papers). Warren H. Schonfeld collaborates with scholars based in United States, United Kingdom and Switzerland. Warren H. Schonfeld's co-authors include Sheila Fifer, Don P. Buesching, Deborah P. Lubeck, Scott C. Flanders, Kathleen F. Villa, Josephine Mauskopf, Frans Rutten, David M. Stier, Peter Mazonson and Vincent Falanga and has published in prestigious journals such as PEDIATRICS, American Journal of Public Health and The American Journal of Medicine.

In The Last Decade

Warren H. Schonfeld

20 papers receiving 596 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Warren H. Schonfeld United States 13 150 142 109 102 91 21 662
J. Mulder Netherlands 11 38 0.3× 71 0.5× 177 1.6× 106 1.0× 33 0.4× 30 739
Sabine Waadt Germany 14 246 1.6× 161 1.1× 100 0.9× 84 0.8× 34 0.4× 20 986
Rudolph A. M. Erdman Netherlands 14 97 0.6× 68 0.5× 48 0.4× 30 0.3× 34 0.4× 24 759
Dorothea Niehoff Germany 11 125 0.8× 64 0.5× 80 0.7× 63 0.6× 44 0.5× 17 710
Brenda Grabsch Australia 16 135 0.9× 240 1.7× 98 0.9× 22 0.2× 31 0.3× 29 1.2k
Rahul K. Dhanda United States 11 53 0.4× 94 0.7× 64 0.6× 18 0.2× 20 0.2× 17 585
Friedrich Balck Germany 15 170 1.1× 75 0.5× 56 0.5× 35 0.3× 14 0.2× 67 792
Hildeberto Correia Portugal 8 69 0.5× 84 0.6× 51 0.5× 27 0.3× 19 0.2× 22 467
Susanne Kuhnt Germany 15 95 0.6× 183 1.3× 106 1.0× 35 0.3× 20 0.2× 32 865
Linda K. Kruus United States 14 56 0.4× 65 0.5× 27 0.2× 46 0.5× 18 0.2× 20 619

Countries citing papers authored by Warren H. Schonfeld

Since Specialization
Citations

This map shows the geographic impact of Warren H. Schonfeld's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Warren H. Schonfeld with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Warren H. Schonfeld more than expected).

Fields of papers citing papers by Warren H. Schonfeld

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Warren H. Schonfeld. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Warren H. Schonfeld. The network helps show where Warren H. Schonfeld may publish in the future.

Co-authorship network of co-authors of Warren H. Schonfeld

This figure shows the co-authorship network connecting the top 25 collaborators of Warren H. Schonfeld. A scholar is included among the top collaborators of Warren H. Schonfeld based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Warren H. Schonfeld. Warren H. Schonfeld is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tong, K., et al.. (2014). Cost-effectiveness analysis of Mammostrat® compared with Oncotype DX® to inform the treatment of breast cancer. ClinicoEconomics and Outcomes Research. 6. 37–37. 6 indexed citations
2.
Michaelis, R., Warren H. Schonfeld, & Siegward‐M. Elsas. (2012). Trigger self-control and seizure arrest in the Andrews/Reiter behavioral approach to epilepsy: A retrospective analysis of seizure frequency. Epilepsy & Behavior. 23(3). 266–271. 30 indexed citations
3.
Schonfeld, Warren H., et al.. (2008). Cost-effectiveness analysis of antifungal prophylaxis in patients undergoing hematopoietic stem cell transplantation. Clinical Therapeutics. 30(5). 964–973. 25 indexed citations
4.
Tashkin, Donald P., Gerald L. Klein, Shoshana Colman, Hany Zayed, & Warren H. Schonfeld. (2007). Comparing COPD Treatment: Nebulizer, Metered Dose Inhaler, and Concomitant Therapy. The American Journal of Medicine. 120(5). 435–441. 26 indexed citations
5.
Colman, Shoshana, et al.. (2004). The Impact of Managed Eye Care on Use of Vision Services, Vision Costs, and Patient Satisfaction. Value in Health. 7(2). 195–203. 2 indexed citations
6.
Mauskopf, Josephine, Frans Rutten, & Warren H. Schonfeld. (2004). Le league tables di costo-efficacia. 6(3). 131–140.
7.
Fifer, Sheila, Don P. Buesching, Curtis J. Henke, et al.. (2003). Functional Status and Somatization as Predictors of Medical Offset in Anxious and Depressed Patients. Value in Health. 6(1). 40–50. 15 indexed citations
8.
Mauskopf, Josephine, Frans Rutten, & Warren H. Schonfeld. (2003). Cost-Effectiveness League Tables. PharmacoEconomics. 21(14). 991–1000. 46 indexed citations
9.
Brod, Meryl, et al.. (2002). Prospective Study Designs in Outcomes Research. PharmacoEconomics. 20(11). 715–725. 3 indexed citations
10.
Schonfeld, Warren H., et al.. (2001). Economic Evaluation of a 2-Dose Hepatitis B Vaccination Regimen for Adolescents. PEDIATRICS. 108(2). 317–325. 15 indexed citations
11.
Stier, David M., et al.. (2001). Cost of Treatment for Onychomycosis. PharmacoEconomics. 19(3). 267–279. 8 indexed citations
12.
Penson, David F., Warren H. Schonfeld, Scott C. Flanders, et al.. (2001). Relationship of first-year costs of treating localized prostate cancer to initial choice of therapy and stage at diagnosis: results from the CaPSURE database. Urology. 57(3). 499–503. 27 indexed citations
14.
Schonfeld, Warren H., Kathleen F. Villa, John Fastenau, Peter Mazonson, & Vincent Falanga. (2000). An economic assessment of Apligraf® (Graftskin) for the treatment of hard‐to‐heal venous leg ulcers. Wound Repair and Regeneration. 8(4). 251–257. 70 indexed citations
15.
Grossfeld, Gary D., David M. Stier, Scott C. Flanders, et al.. (1998). USE OF SECOND TREATMENT FOLLOWING DEFINITIVE LOCAL THERAPY FOR PROSTATE CANCER: DATA FROM THE caPSURE DATABASE. The Journal of Urology. 160(4). 1398–1404. 90 indexed citations
16.
Grossfeld, Gary D., David M. Stier, Scott C. Flanders, et al.. (1998). USE OF SECOND TREATMENT FOLLOWING DEFINITIVE LOCAL THERAPY FOR PROSTATE CANCER. The Journal of Urology. 1398–1404. 1 indexed citations
17.
Schonfeld, Warren H., Eric P. Elkin, Eugene A. Woltering, et al.. (1998). The Cost-Effectiveness of Octreotide Acetate in the Treatment of Carcinoid Syndrome and Vipoma. International Journal of Technology Assessment in Health Care. 14(3). 514–525. 7 indexed citations
18.
Schonfeld, Warren H., et al.. (1997). The functioning and well-being of patients with unrecognized anxiety disorders and major depressive disorder. Journal of Affective Disorders. 43(2). 105–119. 211 indexed citations
19.
Schonfeld, Warren H., et al.. (1992). Predictive factors for controlling seizures using a behavioural approach. Seizure. 1(2). 111–116. 29 indexed citations
20.
Schonfeld, Warren H.. (1981). Estimating Dental Treatment Needs From Epidemiological Data*. Journal of Public Health Dentistry. 41(1). 25–32. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026